BioLineRx Ltd.
Pembelian

Mean reversion for BLRX

179
BLRX dumped over 40% yesterday on dilution news, an overreaction from the market imo. Bought the bottom around $0.15 which is way undervalued for what the company has in the pipeline. Company is now cash healthy for a while with $10 million for research. It's trading at $1,49 on the TASE - so heavy arbitrage opportunity for market makers here. Next to that, it has a buy rating and target for 9.00/share - that was pre-dilution, so you know what, let's cut that in half to $4.50 - works for me too.

Buying the blood and targeting a 100 to 500% move for mean reversion.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.